on may 14, the jinfeng laboratory located in the western (chongqing) science city held a 2022-2023 scientific and technological achievements conference and released 7 scientific and technological innovation achievements, covering basic research on immunopathology, digital pathology equipment, pathological artificial intelligence diagnosis, and high-energy level scientific research platform and other aspects.

among the scientific and technological innovation results released this time, liu xindong's team adhered to original innovation and clarified for the first time the impact of il-8 on the onset of glioma and the mechanism of combined blockade treatment, revealing the role of il-8 in building the immunosuppressive microenvironment of glioma. its role in immunotherapy and its potential application value as an immunotherapy target provide new insights into the immunotherapy of brain glioma. the results were published in cancer cell (if=38.5) in march.

he yonghong's team developed the first multiplex immunofluorescence scanning analysis system with independent intellectual property rights, achieving a breakthrough in "stuck neck" technology. the system uses the world's first "high-brightness low-flash light source that combines stimulated emission and spontaneous emission" technology to achieve full coverage of the excitation spectrum from ultraviolet to visible to near-infrared, solving the key problem of multi-channel fluorescence parallel excitation, and has achieved market success sales promotion.

in addition, there are many achievements that reflect the cross-integration of digital intelligence. zhao ze's team developed the first intelligent pathological tissue collection and analysis system to achieve accurate collection of pathological tissue. at the same time, it applied artificial intelligence to the pathological diagnosis process of surgical frozen tissue for the first time to improve diagnosis efficiency and reduce misdiagnosis rate. liang li's team independently developed a modular tool platform for digital pathology intelligent analysis to provide effective tools for basic scientific researchers and pathology experts to use artificial intelligence tools to efficiently interpret pathological images and improve the efficiency of pathology research.

jinfeng laboratory cooperates with leading domestic companies to carry out integrated application innovation and builds an automated one-stop single-cell transcriptome platform with independent intellectual property rights. it has an automated sample pre-processing workstation, a high-throughput single-cell multi-omics library construction system, and a the original gene sequencing platform of cmos chip, coupled with the original single-cell transcriptomics online analysis system, has become the first integrated, automated, one-stop single-cell transcriptome platform in china. this platform will provide strong technical support for original innovation in life sciences and help jinfeng laboratory build an open, hub and platform innovation highland.

after the press conference, jinfeng laboratory held a docking meeting with relevant departments of the chongqing high-tech zone in the western science city. the research and development team of scientific research results, cooperative enterprises, venture capital institutions, etc. carried out docking around the implementation of results, market docking and project financing to further promote scientific research results. transformation comes to fruition. guangzhou kunyuan fangqing company actively expressed its intention to settle in chongqing high-tech zone; proxima venture partners expressed strong interest in some of the results and are already actively connecting with them.

since its inauguration in june 2022, jinfeng laboratory has taken "next generation diagnosis of major diseases" as its core mission, innovated the scientific research organization paradigm, and explored the integrated design of "basic research-applied basic research-result transformation". actively integrate into the era of digital transformation, promote the integration of digital technology and biotechnology, make full use of modern technologies such as artificial intelligence, carry out technological application innovation, and promote the in-depth and organic integration of science, technology, and engineering. build a high-energy scientific and technological innovation platform, achieve "stuck" technological breakthroughs in key scientific research instruments and equipment and underlying systems, and turn the competitiveness of the platform into a cohesive force for talents.

in the next step, jinfeng laboratory will promote various work with more open ideas and reform measures, attract the world's top scientific and technological talents, carry out original innovation, break through "stuck neck" technology, and form more innovative results that are recognizable to chongqing. promote the virtuous cycle of technology-industry-finance and strive to build an important source of life and health innovation as soon as possible.